M
Melissa Weissner
Researcher at University of Fribourg
Publications - 18
Citations - 575
Melissa Weissner is an academic researcher from University of Fribourg. The author has contributed to research in topics: Acute coronary syndrome & Percutaneous coronary intervention. The author has an hindex of 9, co-authored 16 publications receiving 509 citations.
Papers
More filters
Journal ArticleDOI
Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors.
Serban Puricel,Florim Cuculi,Melissa Weissner,Axel Schmermund,Peiman Jamshidi,Tobias Nyffenegger,Harald Binder,Holger Eggebrecht,Thomas Münzel,Stéphane Cook,Tommaso Gori +10 more
TL;DR: The 12-month incidence of ScT reached 3% and could be significantly reduced when an optimized implantation strategy was employed, an effect that remained significant when adjusted for multivariable propensity score.
Journal ArticleDOI
Coronary evaginations and peri-scaffold aneurysms following implantation of bioresorbable scaffolds: incidence, outcome, and optical coherence tomography analysis of possible mechanisms
Tommaso Gori,Thomas Jansen,Melissa Weissner,Nicolas Foin,Philip Wenzel,Eberhard Schulz,Stéphane Cook,Thomas Münzel +7 more
TL;DR: Optical coherence tomography-detected evaginations are relatively common after BVS implantation, but, as for modern drug-eluting metallic stents, major evagination are very rare.
Journal ArticleDOI
Optical Coherence Tomography Findings in Bioresorbable Vascular Scaffolds Thrombosis
Florim Cuculi,Serban Puricel,Peiman Jamshidi,Jérémy Valentin,Zacharenia Kallinikou,Stefan Toggweiler,Melissa Weissner,Thomas Münzel,Stéphane Cook,Tommaso Gori +9 more
TL;DR: The mechanisms of early ScT seem to be similar to metallic stents (mechanical and inadequate antiplatelet therapy) and the predominant finding in late and very late ScT is peristrut low-intensity area.
Journal ArticleDOI
Clinical, Angiographic, Functional, and Imaging Outcomes 12 Months After Implantation of Drug-Eluting Bioresorbable Vascular Scaffolds in Acute Coronary Syndromes.
Tommaso Gori,Eberhard Schulz,Ulrich Hink,Madeleine Kress,Nadja Weiers,Melissa Weissner,Alexander Jabs,Philip Wenzel,Davide Capodanno,Thomas Münzel +9 more
TL;DR: Twelve months after BVS implantation, clinical, intracoronary imaging, and vasomotion data appear to provide a rationale for the use of BVS in the setting of ACS and the basis for a randomized study.
Journal ArticleDOI
Characteristics, Predictors, and Mechanisms of Thrombosis in Coronary Bioresorbable Scaffolds: Differences Between Early and Late Events.
Tommaso Gori,Melissa Weissner,Svenja Gönner,Franziska Wendling,Helen Ullrich,Stephen G. Ellis,Remzi Anadol,Alberto Polimeni,Thomas Münzel +8 more
TL;DR: Different mechanisms underlie early and late ScT: although incomplete BRS deployment was a predictor of the former, the latter was associated with large vessel size and BRS undersizing, which is significantly less frequent with an optimized implantation technique.